News & Updates
Filter by Specialty:
Drug monitoring may prevent weight gain in ASD patients taking aripiprazole
27 Sep 2023
byStephen Padilla
A recent study exploring the relationship between aripiprazole pharmacokinetics (PK), side effects, and effectiveness in children and adolescents with autism spectrum disorder (ASD) has found that higher plasma levels correlate with greater weight gain.
Drug monitoring may prevent weight gain in ASD patients taking aripiprazole
27 Sep 2023Atezolizumab-chemo confers durable survival benefit in ES-SCLC
27 Sep 2023
byAudrey Abella
In the merged analysis of the IMpower133 trial and IMbrella A open-label extension study, the combination of the PD-L1 inhibitor atezolizumab and a chemotherapy regimen comprising carboplatin and etoposide (CP/ET) demonstrated potential for survival benefit of up to 5 years in patients with extensive stage-small-cell lung cancer (ES-SCLC).